IceCure Medical (ICCM) Gross Profit (2020 - 2026)

IceCure Medical (ICCM) has reported Gross Profit for 7 consecutive years, with $253000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Profit rose 93.13% year-over-year to $253000.0 in Q2 2026; TTM through Jun 2026 was $1.4 million, a 42.36% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, down 15.51% from the prior year.
• Gross Profit was $253000.0 for Q2 2026 at IceCure Medical, down from $295000.0 in the prior quarter.
• Over five years, Gross Profit peaked at $600000.0 in Q4 2025 and troughed at -$23000.0 in Q3 2023.
• A 5-year average of $331666.7 and a median of $307500.0 in 2023 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit plunged 113.86% in 2023 and surged 1121.74% in 2024, its largest moves.
• Over 5 years, Gross Profit stood at $461000.0 in 2022, then grew by 23.43% to $569000.0 in 2023, then fell by 26.71% to $417000.0 in 2024, then soared by 43.88% to $600000.0 in 2025, then tumbled by 57.83% to $253000.0 in 2026.
• The last three Gross Profit figures came in at $253000.0 (Q2 2026), $295000.0 (Q1 2026), and $600000.0 (Q4 2025), per Business Quant data.